Bridge doses first patient in Phase lla trial of IPF therapy

Bridge doses first patient in Phase lla trial of IPF therapy

Submitted by admin on April 13, 2023 - 11:55am
Source: 
Clinical Trials Arena
News Tags: 
Bridge Biotherapeutics
clinical trials
BBT-877
IPF
Headline: 
Bridge doses first patient in Phase lla trial of IPF therapy
snippet: 

South Korean biotech firm Bridge Biotherapeutics has dosed the first patient in its Phase lla trial of BBT-877 to treat patients with idiopathic pulmonary fibrosis (IPF).

Do Not Allow Advertisers to Use My Personal information